Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/19156831

Download in:

View as

General Info

PMID
19156831